#29 – Professor Omid Veiseh and Paul Cherukuri, Chief Innovation Officer at Rice University

Share This Post

In this episode we discuss:

Join us on the latest episode! Our Guests: Professor Omid Veiseh and Paul Cherukuri, Chief Innovation Officer at Rice University.

What you’ll get out of this episode:
  • The vision and strategies behind the Launchpad
  • Houston as a key location for medical innovation
  • Impact on the local and national biotech scene
  • Upcoming projects and future prospects in biotechnology

Watch

Listen

Read

Introduction

In a groundbreaking episode of the “Bio Breakthroughs” podcast, host Jared S. Taylor explores the cutting-edge world of biotechnological innovations with the key figures behind Rice University’s Biotech Launchpad. This revolutionary platform is reshaping the landscape of biotech advancements.

The Vision Behind Rice Biotech Launchpad

The episode introduces us to the minds behind the Launchpad: Professor Omid Veiseh and Paul Cherukuri, Chief Innovation Officer at Rice University. They share the vision of the Launchpad – a venture creation firm rather than a traditional accelerator, focusing on bridging the gap between laboratory discoveries and commercialization.

Unique Strategies for Success

The conversation delves into the strategies that set Rice Biotech Launchpad apart from other biotech accelerators. Veiseh and Cherukuri emphasize their method of starting with clinical unmet needs and creating ventures around disruptive technologies. They highlight the importance of understanding patient care gaps and developing technologies that cater to these needs.

Houston: A Hub for Medical Innovation

Jared S. Taylor points out the strategic location of the Launchpad in Houston, home to the world’s largest medical center. The guests elaborate on how this positioning benefits the Launchpad, providing easy access to clinical trials and a rich ecosystem for medical innovation.

Impacting the Local and National Biotech Scene

The podcast sheds light on the Launchpad’s influence beyond Houston, attracting interest from national venture capitalists and pharma leaders. The initiative is recognized for bringing innovative technologies to the forefront, contributing significantly to the national biotech landscape.

Measuring Success and Future Prospects

The guests discuss their metrics for success, focusing on clinical translation and the development of innovative projects. They also tease some of the exciting projects currently in the pipeline, hinting at future announcements and the continued growth of the Launchpad.

Slice of Healthcare Wrap Up

The episode wraps up with reflections on the unique position of Rice Biotech Launchpad in the biotech innovation world. It’s not just about creating groundbreaking technologies but also about fostering a vibrant community that brings together scientists, clinicians, and business minds.

WORD FROM OUR SPONSORS:

Our sponsor for this episode are Sage Growth Partners.

Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media – @sagegrowthpartners

To learn more about our guests and their companies:

Guest’s LinkedInGuest’s LinkedInLinkedIn – Website


Also, be sure to follow Slice of Healthcare on our social channels:

– Website  – LinkedIn – Twitter – YouTube – Newsletter

More To Explore

Total
0
Share